Overview and Scope
Solid tumor cancer treatment refers to the treatment of an aberrant mass of tissue that does not generally contain cysts or liquid regions. Solid tumors include cancers of the brain, ovary, breast, colon, and other organs. The majority of the tumor’s cells are created by cancer stem cells through division.
Sizing and Forecast
The solid tumor cancer treatment market size has grown rapidly in recent years. It will grow from $200.53 billion in 2023 to $230.8 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to advancements in research and development, drug development and approvals, increased cancer incidence rates, growing aging population, patient advocacy and awareness.
The solid tumor cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $382.85 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to personalized medicine trends, immunotherapy advancements, global health challenges and emerging diseases, regulatory frameworks and drug approvals, shifts in healthcare financing and reimbursement models. Major trends in the forecast period include immunotherapy advancements, precision medicine and biomarker identification, combination therapies, digital health integration, technological innovations in treatment modalities.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report
Segmentation & Regional Insights
The solid tumor cancer treatment market covered in this report is segmented –
1) By Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures
2) By Application: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications
3) By End-Users: Hospitals, Research Institutes, Homecare
North America was the largest region in the solid tumor cancer treatment market in 2023. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9909&type=smp
Major Driver Impacting Market Growth
The increasing incidence of cancer significantly contributes to the growth of the solid tumor cancer treatment market going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. Solid tumor cancer treatment refers to a treatment that is used to remove the solid tumor from the body of patients who have cancer. For instance, in 2022, according to a report by the American Cancer Society, the estimated number of new cancer Cases in 2021 was 1,898,160, which increased to 1,918,030 in 2022. Therefore, an increasing incidence of cancer is driving the growth of the solid tumor cancer treatment market.
Key Industry Players
Major companies operating in the solid tumor cancer treatment market report are AstraZeneca PLC, Amgen Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Olympus Medical Systems, Astellas Pharma Inc., Celgene Corporation, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Celldex Therapeutics Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., Exelixis Inc., Genentech Inc., Gilead Sciences Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., Janssen Biotech Inc., Karyopharm Therapeutics Inc., Kyowa Kirin Co. Ltd., MedImmune LLC, Medivation Inc., Millennium Pharmaceuticals Inc., MorphoSys AG, Onyx Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Seattle Genetics Inc., Spectrum Pharmaceuticals Inc., Taiho Pharmaceutical Co. Ltd., Tesaro Inc., Verastem Inc., Zymeworks Inc. .
The solid tumor cancer treatment market report table of contents includes:
1. Executive Summary
2. Solid Tumor Cancer Treatment Market Characteristics
3. Solid Tumor Cancer Treatment Market Trends And Strategies
4. Solid Tumor Cancer Treatment Market – Macro Economic Scenario
5. Global Solid Tumor Cancer Treatment Market Size and Growth
.
.
.
31. Global Solid Tumor Cancer Treatment Market Competitive Benchmarking
32. Global Solid Tumor Cancer Treatment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Solid Tumor Cancer Treatment Market
34. Solid Tumor Cancer Treatment Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
